佛手宁神方改善睡眠作用的机制

目的评价佛手宁神方镇静催眠作用并研究其对失眠大鼠海马5-羟色胺(5-HT)、5-羟色胺1A受体(5-HT1AR)表达的影响。方法雄性昆明小鼠随机分为空白组,艾司唑仑组[0.4 mg/(kg·d)],佛手宁神方低、中、高剂量组[12,24,48 g/(kg·d)];连续给药1周,末次给药后进行阈下剂量和阈剂量戊巴比妥钠致小鼠睡眠实验。雄性SD大鼠随机分为空白组,模型组,艾司唑仑组[0.2 mg/(kg·d)],佛手宁神方低、中、高剂量组[6,12,24 g/(kg·d)],每组8只;采用腹腔注射对氯苯丙氨酸(PCPA)350 mg/(kg·d)制作失眠大鼠模型;造模完成后第1天开始灌胃给药,连续...

Full description

Saved in:
Bibliographic Details
Published in南方医科大学学报 Vol. 37; no. 8; pp. 1116 - 1120
Main Author 黄杰聪 谢炜 邓宁 梁雯琳 胡冬蓉 洪雨 周扬
Format Journal Article
LanguageChinese
Published 南方医科大学中医药学院,广东 广州,510515 2017
Subjects
Online AccessGet full text
ISSN1673-4254
DOI10.3969/j.issn.1673-4254.2017.08.19

Cover

More Information
Summary:目的评价佛手宁神方镇静催眠作用并研究其对失眠大鼠海马5-羟色胺(5-HT)、5-羟色胺1A受体(5-HT1AR)表达的影响。方法雄性昆明小鼠随机分为空白组,艾司唑仑组[0.4 mg/(kg·d)],佛手宁神方低、中、高剂量组[12,24,48 g/(kg·d)];连续给药1周,末次给药后进行阈下剂量和阈剂量戊巴比妥钠致小鼠睡眠实验。雄性SD大鼠随机分为空白组,模型组,艾司唑仑组[0.2 mg/(kg·d)],佛手宁神方低、中、高剂量组[6,12,24 g/(kg·d)],每组8只;采用腹腔注射对氯苯丙氨酸(PCPA)350 mg/(kg·d)制作失眠大鼠模型;造模完成后第1天开始灌胃给药,连续1周。旷场实验测试各组大鼠运动总路程和站立次数;酶联免疫吸附法测定海马5-HT的含量;免疫组化法和实时荧光定量PCR分别检测海马5-HT1AR蛋白和m RNA的表达。结果与空白组相比,佛手宁神方高剂量组阈下剂量戊巴比妥钠致小鼠入睡只数增加(P〈0.05),阈剂量戊巴比妥钠致小鼠睡眠潜伏期缩短(P〈0.01),睡眠持续时间延长(P〈0.01)。与空白组比较,模型组大鼠在旷场实验中运动总路程增加(P〈0.05),海马5-HT含量减少(P〈0.01),海马5-HT1AR蛋白和m RNA表达水平下降(P〈0.01)。与模型组相比,艾司唑仑组和佛手宁神方高剂量组运功总路程减少(P〈0.05),海马5-HT含量增加(P〈0.05),海马5-HT1AR蛋白和m RNA表达水平上升(P〈0.01)。结论佛手宁神方可能通过提高海马5-HT的含量,上调海马5-HT1AR蛋白和m RNA的表达,从而起到治疗失眠的作用。
Bibliography:44-1627/R
HUANG Jiecong, XIE Wei, DENG Ning, LIANG Wenlin, HU Dongrong, HONG Yu, ZHOU Yang (College of Traditional Chinese Medicine,-Southern Medical University, ~angzhou 510515, China)
Objective To evaluate the sedative and hypnotic effects of Foshouningshen decoction (FSNSD) and study its effects on expressions of 5-hydroxy tryptamine (5-HT) and 5-HT1A receptor (5-HT1AR) in the hippocampus in a rat model of insomnia. Methods Male KM mice were divided into control group, estazolam (0.4 mg/kg daily) group, and low-, moderate-, and high-dose FSNSD groups (daily dose of 12, 24, and 48 g/kg, respectively). After corresponding treatments for 1 week, the mice underwent sleep-inducing test with subthreshold and threshold doses of sodium pentobarbital. Forty-eight male SD rats were randomized into control group, insomnia model group, estazolam group (0.2 mg/kg daily), and low-, moderate-, and high-dose FSNSD groups (with daily dose of 6, 12, and 24 g/kg, respectively). Rat models of insomnia were established by intrap
ISSN:1673-4254
DOI:10.3969/j.issn.1673-4254.2017.08.19